Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data.
Ontology highlight
ABSTRACT: The HIV pandemic has led to close to 40 million people living with HIV (PLWH) worldwide. To date, SARS-CoV2 has affected > 220 million people, and unprecedented global efforts have resulted in almost 6000 million doses of SARS-CoV2 vaccines being administered. Although several specific COVID-19 antiviral and anti-inflammatory treatments and SARS-CoV2 vaccines have been approved, the data available to support their use in specific populations such as PLWH remain limited. PLWH includes a range of individuals from practically unaffected immunity to severely immunocompromised individuals, and preventive and therapeutic interventions should be tailored for these subgroups . However, in most randomized clinical trials regarding antivirals, immunomodulators and vaccines for COVID-19, PLWH have be
SUBMITTER: Diaz NA
PROVIDER: S-EPMC8552207 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA